Covina, CANCT07743450Now EnrollingIRB Ready

Obesity Clinical Trial in Covina, CA

Access cutting-edge obesity treatment through this phase 3 clinical trial at a research site in Covina. Study-provided care at no cost to qualified participants.

Sponsored by Ascletis Pharma (China) Co., Limited

Quick Self-Assessment

See if you qualify for this Covina location

Preparing your pre-screening questions…

Expert Care in Covina

Access obesity specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related obesity treatment provided free

Apply for This Covina Location

Check if you qualify for this obesity clinical trial in Covina, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Covina

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Covina site if eligible
  4. 4Begin participation

About This Obesity Study in Covina

Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability of three maintenance doses of once-daily oral ASC30 compared with placebo in participants with obesity or overweight and T2DM.

Sponsor: Ascletis Pharma (China) Co., Limited

Who Can Participate

Inclusion Criteria

Participant must be ≥18 years of age inclusive, or the legal age of consent in the jurisdiction in which the study is taking place at screening.
Have a BMI ≥ 27 kg/m2 at screening.
Have a history of at least 1 self-reported unsuccessful dietary effort to lose body weight.
Have a diagnosis of T2D according to the WHO classification or other locally applicable standards, with HbA1c \> 6.5% (48 mmol/mol) to ≤10.5% (91 mmol/mol) at screening.

Exclusion Criteria

Have Type 1 Diabetes Mellitus (T1DM), history of ketoacidosis or hyperosmolar state/coma, or any other types of diabetes except T2DM.
Have a self-reported change in body weight \>5 kg (11 pounds) within 3 months prior to screening.
Have an estimated glomerular filtration rate (eGFR) \< 15 mL/min/1.73 m2, as determined by the laboratory at screening.
Have a history of acute or chronic pancreatitis any time prior to screening.
Have known allergies or intolerance to glucagon-like peptide-1 Receptor Agonists (GLP-1 RA).
Participants with a personal or family (first-degree relative) history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia (MEN) syndrome type 2.
Are currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Covina?

Yes, this clinical trial (NCT07743450) has an active research site in Covina, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Obesity Treatment Options in Covina, CA

If you're searching for obesity treatment options in Covina, CA, this clinical trial (NCT07743450) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Covina research site is actively enrolling participants for this phase 3 clinical trial. You'll receive care from experienced obesity specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all obesity clinical trials near you to find additional studies recruiting in your area.

More Obesity Trials in Covina, CA

See all obesity clinical trials recruiting in Covina — not just this study.

Browse Obesity Trials in Covina →

Browse More Trials by Condition

Obesity TrialsPediatric Obesity TrialsObesity Hypoventilation Syndrome TrialsAll Conditions →

Ready to Join in Covina?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Covina, CA